1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Gelasco, A. Lippard, S.J. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 Cl2 H6 N2 Pt 300.045 Cisplatin diammine(dichloro)platinum non-polymer C10 H14 N5 O6 P 331.222 y 2'-DEOXYADENOSINE-5'-MONOPHOSPHATE DNA linking C9 H14 N3 O7 P 307.197 y 2'-DEOXYCYTIDINE-5'-MONOPHOSPHATE DNA linking C10 H14 N5 O7 P 347.221 y 2'-DEOXYGUANOSINE-5'-MONOPHOSPHATE DNA linking C10 H15 N2 O8 P 322.208 y THYMIDINE-5'-MONOPHOSPHATE DNA linking N 1 N PT N 2 N N N 3 N N N 4 N H N 5 N H N 6 N H N 7 N H N 8 N CL N 9 N CL N 10 N H N 11 N H N 12 N O N 13 N P N 14 N O N 15 N O N 16 N O N 17 N C N 18 R C N 19 N O N 20 S C N 21 N O N 22 N C N 23 R C Y 24 N N Y 25 N C Y 26 N N Y 27 N C Y 28 N C N 29 N N Y 30 N N Y 31 N C Y 32 N N Y 33 N C N 34 N H N 35 N H N 36 N H N 37 N H N 38 N H N 39 N H N 40 N H N 41 N H N 42 N H N 43 N H N 44 N H N 45 N H N 46 N H N 47 N H N 48 N O N 49 N P N 50 N O N 51 N O N 52 N O N 53 N C N 54 R C N 55 N O N 56 S C N 57 N O N 58 N C N 59 R C N 60 N N N 61 N C N 62 N O N 63 N N N 64 N C N 65 N N N 66 N C N 67 N C N 68 N H N 69 N H N 70 N H N 71 N H N 72 N H N 73 N H N 74 N H N 75 N H N 76 N H N 77 N H N 78 N H N 79 N H N 80 N H N 81 N H N 82 N O N 83 N P N 84 N O N 85 N O N 86 N O N 87 N C N 88 R C N 89 N O N 90 S C N 91 N O N 92 N C N 93 R C Y 94 N N Y 95 N C Y 96 N N Y 97 N C N 98 N C N 99 N O N 100 N N N 101 N C N 102 N N N 103 N N Y 104 N C N 105 N H N 106 N H N 107 N H N 108 N H N 109 N H N 110 N H N 111 N H N 112 N H N 113 N H N 114 N H N 115 N H N 116 N H N 117 N H N 118 N H N 119 N O N 120 N P N 121 N O N 122 N O N 123 N O N 124 N C N 125 R C N 126 N O N 127 S C N 128 N O N 129 N C N 130 R C N 131 N N N 132 N C N 133 N O N 134 N N N 135 N C N 136 N O N 137 N C N 138 N C N 139 N C N 140 N H N 141 N H N 142 N H N 143 N H N 144 N H N 145 N H N 146 N H N 147 N H N 148 N H N 149 N H N 150 N H N 151 N H N 152 N H N 153 N H N 154 N H N 1 N sing N 2 N sing N 3 N sing N 4 N sing N 5 N sing N 6 N sing N 7 N sing N 8 N sing N 9 N sing N 10 N sing N 11 N sing N 12 N sing N 13 N doub N 14 N sing N 15 N sing N 16 N sing N 17 N sing N 18 N sing N 19 N sing N 20 N sing N 21 N sing N 22 N sing N 23 N sing N 24 N sing N 25 N sing N 26 N sing N 27 N sing N 28 N sing N 29 N sing N 30 N sing N 31 N sing N 32 N sing N 33 N sing Y 34 N sing Y 35 N sing Y 36 N doub N 37 N sing Y 38 N sing Y 39 N sing Y 40 N doub N 41 N sing Y 42 N doub N 43 N sing N 44 N sing Y 45 N sing Y 46 N doub N 47 N sing Y 48 N sing N 49 N sing N 50 N sing N 51 N doub N 52 N sing N 53 N sing N 54 N sing N 55 N sing N 56 N sing N 57 N sing N 58 N sing N 59 N sing N 60 N sing N 61 N sing N 62 N sing N 63 N sing N 64 N sing N 65 N sing N 66 N sing N 67 N sing N 68 N sing N 69 N sing N 70 N sing N 71 N sing N 72 N sing N 73 N sing N 74 N doub N 75 N sing N 76 N doub N 77 N sing N 78 N sing N 79 N sing N 80 N sing N 81 N doub N 82 N sing N 83 N sing N 84 N sing N 85 N sing N 86 N doub N 87 N sing N 88 N sing N 89 N sing N 90 N sing N 91 N sing N 92 N sing N 93 N sing N 94 N sing N 95 N sing N 96 N sing N 97 N sing N 98 N sing N 99 N sing N 100 N sing N 101 N sing N 102 N sing N 103 N sing N 104 N sing N 105 N sing N 106 N sing Y 107 N sing Y 108 N sing Y 109 N doub N 110 N sing Y 111 N sing N 112 N sing Y 113 N doub N 114 N doub N 115 N sing N 116 N sing N 117 N sing N 118 N sing N 119 N doub N 120 N sing N 121 N sing N 122 N sing N 123 N sing N 124 N sing N 125 N doub N 126 N sing N 127 N sing N 128 N sing N 129 N sing N 130 N sing N 131 N sing N 132 N sing N 133 N sing N 134 N sing N 135 N sing N 136 N sing N 137 N sing N 138 N sing N 139 N sing N 140 N sing N 141 N sing N 142 N sing N 143 N sing N 144 N sing N 145 N sing N 146 N sing N 147 N sing N 148 N doub N 149 N sing N 150 N sing N 151 N sing N 152 N doub N 153 N sing N 154 N sing N 155 N doub N 156 N sing N 157 N sing N 158 N sing N 159 N sing US Biochemistry BICHAW 0033 0006-2960 37 9230 9239 10.1021/bi973176v 9649303 NMR solution structure of a DNA dodecamer duplex containing a cis-diammineplatinum(II) d(GpG) intrastrand cross-link, the major adduct of the anticancer drug cisplatin. 1998 10.2210/pdb1a84/pdb pdb_00001a84 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 CISPLATIN INTRASTRAND CROSS-LINKED DNA 3565.316 DNA D(CCTCTG*G*TCTCC) 1 syn polymer CISPLATIN INTRASTRAND CROSS-LINKED DNA 3761.468 DNA D(GGAGACCAGAGG) 1 syn polymer 300.045 Cisplatin 1 syn non-polymer no no (DC)(DC)(DT)(DC)(DT)(DG)(DG)(DT)(DC)(DT)(DC)(DC) CCTCTGGTCTCC A polydeoxyribonucleotide no no (DG)(DG)(DA)(DG)(DA)(DC)(DC)(DA)(DG)(DA)(DG)(DG) GGAGACCAGAGG B polydeoxyribonucleotide n n n n n n n n n n n n n n n n n n n n n n n n 5.075 1 19 A 1 B 24 -1.678 A_DC1:DG24_B 1 2.470 0.126 -0.327 -0.095 -6.510 1 19 A 2 B 23 -0.867 A_DC2:DG23_B 2 -6.609 0.263 -0.069 -0.116 4.523 1 20 A 3 B 22 2.427 A_DT3:DA22_B 3 -8.763 0.083 -0.484 -0.186 5.927 1 19 A 4 B 21 -1.899 A_DC4:DG21_B 4 7.761 0.062 -0.331 -0.088 -2.401 1 20 A 5 B 20 1.507 A_DT5:DA20_B 5 25.824 0.132 0.529 -0.240 33.274 1 19 A 6 B 19 15.784 A_DG6:DC19_B 6 -6.563 0.702 -0.669 -0.581 -1.050 1 19 A 7 B 18 -0.752 A_DG7:DC18_B 7 -9.684 -0.664 -0.126 -0.233 21.175 1 20 A 8 B 17 -2.357 A_DT8:DA17_B 8 -1.188 -0.106 -0.445 -0.082 8.307 1 19 A 9 B 16 1.406 A_DC9:DG16_B 9 -14.943 0.217 -0.549 -0.133 -10.506 1 20 A 10 B 15 -0.088 A_DT10:DA15_B 10 -6.205 -0.167 0.413 -0.137 14.907 1 19 A 11 B 14 -1.446 A_DC11:DG14_B 11 -8.118 0.318 -0.442 -0.118 -22.480 1 19 A 12 B 13 -1.889 A_DC12:DG13_B 12 18.772 0.383 0.186 -0.098 4.502 34.447 A A 1 2 17.110 B B 24 23 4.558 9.991 0.631 0.365 AA_DC1DC2:DG23DG24_BB 1 1.826 -3.127 32.960 -1.586 -0.662 2.323 23.374 A A 2 3 23.980 B B 23 22 3.045 9.443 -0.690 -1.219 AA_DC2DT3:DA22DG23_BB 2 -0.643 1.633 21.396 -5.769 1.514 3.848 32.869 A A 3 4 -5.906 B B 22 21 3.789 -3.323 -0.234 -0.875 AA_DT3DC4:DG21DA22_BB 3 -5.172 9.191 32.305 -0.876 -0.628 3.744 30.662 A A 4 5 24.424 B B 21 20 4.710 12.510 0.212 -1.235 AA_DC4DT5:DA20DG21_BB 4 -4.326 8.447 27.720 -5.692 -1.562 1.122 26.871 A A 5 6 54.273 B B 20 19 2.906 20.344 -0.094 -0.136 AA_DT5DG6:DC19DA20_BB 5 13.200 -35.214 11.660 -4.843 3.155 -0.049 42.819 A A 6 7 85.858 B B 19 18 4.510 42.348 -0.299 -0.376 AA_DG6DG7:DC18DC19_BB 6 -5.795 11.750 2.619 -6.202 -0.369 3.302 34.960 A A 7 8 5.994 B B 18 17 3.405 3.588 -0.706 0.129 AA_DG7DT8:DA17DC18_BB 7 3.982 -6.653 34.559 -0.343 1.795 3.779 40.845 A A 8 9 0.999 B B 17 16 3.777 0.697 0.345 -0.725 AA_DT8DC9:DG16DA17_BB 8 2.807 -4.025 40.747 -1.127 -0.137 4.358 33.454 A A 9 10 -1.353 B B 16 15 4.406 -0.777 -0.042 0.496 AA_DC9DT10:DA15DG16_BB 9 -4.752 8.283 33.116 1.034 -0.984 2.061 53.556 A A 10 11 -36.456 B B 15 14 3.114 -31.005 0.057 0.961 AA_DT10DC11:DG14DA15_BB 10 5.215 -6.132 43.919 2.792 0.227 3.497 43.038 A A 11 12 53.944 B B 14 13 5.671 34.458 0.977 0.115 AA_DC11DC12:DG13DG14_BB 11 -3.164 4.953 25.994 -5.937 -1.892 chem_comp_atom chem_comp_bond database_2 pdbx_database_status struct_conn struct_site repository Initial release Version format compliance Non-polymer description Version format compliance Data collection Database references Derived calculations Other 1 0 1998-11-25 1 1 2008-03-24 1 2 2011-07-13 1 3 2024-04-10 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.process_site _struct_conn.ptnr1_auth_comp_id _struct_conn.ptnr1_auth_seq_id _struct_conn.ptnr1_label_asym_id _struct_conn.ptnr1_label_atom_id _struct_conn.ptnr1_label_comp_id _struct_conn.ptnr1_label_seq_id _struct_conn.ptnr2_auth_comp_id _struct_conn.ptnr2_auth_seq_id _struct_conn.ptnr2_label_asym_id _struct_conn.ptnr2_label_atom_id _struct_conn.ptnr2_label_comp_id _struct_conn.ptnr2_label_seq_id _struct_site.pdbx_auth_asym_id _struct_site.pdbx_auth_comp_id _struct_site.pdbx_auth_seq_id Y BNL 1998-04-02 REL CPT Cisplatin THE STRUCTURE WAS DETERMINED USING 2D 1H-1H NMR SPECTROSCOPY IN BOTH D2O AND H2O SOLUTIONS LEAST RESTRAINT VIOLATION 1 1 2D1HNOESY TOCSY PECOSY 100 mM NACL 6.9 1 atm 288 K REFINEMENT DETAILS CAN BE FOUND IN THE JRNL CITATION ABOVE. NOE-RESTRAINED REFINEMENT D2O/H2O BRUNGER refinement X-PLOR structure solution X-PLOR structure solution QUANTA 750 FRANCIS BITTER MAGNET LAB CUSTOM BUILT FBML 750 CPT 1 3 CPT CPT 13 A C 1 n 1 DC 1 A C 2 n 2 DC 2 A T 3 n 3 DT 3 A C 4 n 4 DC 4 A T 5 n 5 DT 5 A G 6 n 6 DG 6 A G 7 n 7 DG 7 A T 8 n 8 DT 8 A C 9 n 9 DC 9 A T 10 n 10 DT 10 A C 11 n 11 DC 11 A C 12 n 12 DC 12 A G 13 n 1 DG 13 B G 14 n 2 DG 14 B A 15 n 3 DA 15 B G 16 n 4 DG 16 B A 17 n 5 DA 17 B C 18 n 6 DC 18 B C 19 n 7 DC 19 B A 20 n 8 DA 20 B G 21 n 9 DG 21 B A 22 n 10 DA 22 B G 23 n 11 DG 23 B G 24 n 12 DG 24 B author_defined_assembly 2 dimeric A DG 6 A N7 DG 6 1_555 A CPT 13 C PT1 CPT 1_555 A CPT 13 C N1 CPT 1_555 179.9 A DG 6 A N7 DG 6 1_555 A CPT 13 C PT1 CPT 1_555 A CPT 13 C N2 CPT 1_555 89.8 A CPT 13 C N1 CPT 1_555 A CPT 13 C PT1 CPT 1_555 A CPT 13 C N2 CPT 1_555 90.1 A DG 6 A N7 DG 6 1_555 A CPT 13 C PT1 CPT 1_555 A DG 7 A N7 DG 7 1_555 90.1 A CPT 13 C N1 CPT 1_555 A CPT 13 C PT1 CPT 1_555 A DG 7 A N7 DG 7 1_555 90.0 A CPT 13 C N2 CPT 1_555 A CPT 13 C PT1 CPT 1_555 A DG 7 A N7 DG 7 1_555 179.7 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 B B H4' OP1 DA DG 15 16 1.48 1 B B H2'' OP2 DG DG 23 24 1.57 1 A A H2'' OP2 DT DC 10 11 1.60 1 A DC 9 0.076 SIDE CHAIN 1 6.42 0.90 103.10 109.52 A A A C4' C3' C2' DC DC DC 1 1 1 N 1 1.97 0.30 108.30 110.27 A A A O4' C1' N1 DC DC DC 1 1 1 N 1 3.99 0.30 108.30 112.29 A A A O4' C1' N1 DC DC DC 2 2 2 N 1 2.98 0.30 108.30 111.28 A A A O4' C1' N1 DT DT DT 3 3 3 N 1 -3.87 0.60 122.90 119.03 A A A C6 C5 C7 DT DT DT 3 3 3 N 1 3.36 0.30 108.30 111.66 A A A O4' C1' N1 DC DC DC 4 4 4 N 1 5.80 0.90 103.10 108.90 A A A C4' C3' C2' DT DT DT 5 5 5 N 1 3.88 0.50 106.80 110.68 A A A O4' C1' C2' DT DT DT 5 5 5 N 1 1.81 0.30 108.30 110.11 A A A O4' C1' N9 DG DG DG 6 6 6 N 1 1.90 0.30 108.30 110.20 A A A O4' C1' N9 DG DG DG 7 7 7 N 1 2.93 0.30 108.30 111.23 A A A O4' C1' N1 DT DT DT 10 10 10 N 1 5.69 0.90 103.10 108.79 A A A C4' C3' C2' DC DC DC 11 11 11 N 1 3.22 0.50 106.80 110.02 A A A O4' C1' C2' DC DC DC 11 11 11 N 1 3.51 0.30 108.30 111.81 A A A O4' C1' N1 DC DC DC 11 11 11 N 1 6.39 0.90 103.10 109.49 A A A C4' C3' C2' DC DC DC 12 12 12 N 1 3.21 0.50 106.80 110.01 A A A O4' C1' C2' DC DC DC 12 12 12 N 1 2.59 0.30 108.30 110.89 A A A O4' C1' N1 DC DC DC 12 12 12 N 1 6.12 0.90 103.10 109.22 B B B C4' C3' C2' DG DG DG 13 13 13 N 1 4.69 0.50 113.10 117.79 B B B N7 C8 N9 DG DG DG 13 13 13 N 1 -2.66 0.40 106.40 103.74 B B B C8 N9 C4 DG DG DG 13 13 13 N 1 5.41 0.90 103.10 108.51 B B B C4' C3' C2' DG DG DG 14 14 14 N 1 4.37 0.50 113.10 117.47 B B B N7 C8 N9 DG DG DG 14 14 14 N 1 -2.98 0.40 106.40 103.42 B B B C8 N9 C4 DG DG DG 14 14 14 N 1 3.70 0.50 113.80 117.50 B B B N7 C8 N9 DA DA DA 15 15 15 N 1 -3.15 0.40 105.80 102.65 B B B C8 N9 C4 DA DA DA 15 15 15 N 1 4.69 0.30 108.30 112.99 B B B O4' C1' N9 DG DG DG 16 16 16 N 1 4.22 0.50 113.10 117.32 B B B N7 C8 N9 DG DG DG 16 16 16 N 1 -2.68 0.40 106.40 103.72 B B B C8 N9 C4 DG DG DG 16 16 16 N 1 6.43 0.90 103.10 109.53 B B B C4' C3' C2' DA DA DA 17 17 17 N 1 3.07 0.30 108.30 111.37 B B B O4' C1' N9 DA DA DA 17 17 17 N 1 3.60 0.50 113.80 117.40 B B B N7 C8 N9 DA DA DA 17 17 17 N 1 5.58 0.90 103.10 108.68 B B B C4' C3' C2' DC DC DC 18 18 18 N 1 4.63 0.30 108.30 112.93 B B B O4' C1' N1 DC DC DC 18 18 18 N 1 5.75 0.90 103.10 108.85 B B B C4' C3' C2' DC DC DC 19 19 19 N 1 2.35 0.30 108.30 110.65 B B B O4' C1' N1 DC DC DC 19 19 19 N 1 3.32 0.30 108.30 111.62 B B B O4' C1' N9 DA DA DA 20 20 20 N 1 3.75 0.50 113.80 117.55 B B B N7 C8 N9 DA DA DA 20 20 20 N 1 -2.52 0.40 105.80 103.28 B B B C8 N9 C4 DA DA DA 20 20 20 N 1 3.03 0.30 108.30 111.33 B B B O4' C1' N9 DG DG DG 21 21 21 N 1 4.36 0.50 113.10 117.46 B B B N7 C8 N9 DG DG DG 21 21 21 N 1 -2.67 0.40 106.40 103.73 B B B C8 N9 C4 DG DG DG 21 21 21 N 1 2.73 0.30 108.30 111.03 B B B O4' C1' N9 DA DA DA 22 22 22 N 1 3.63 0.50 113.80 117.43 B B B N7 C8 N9 DA DA DA 22 22 22 N 1 -5.17 0.80 102.40 97.23 B B B C3' C2' C1' DG DG DG 23 23 23 N 1 3.39 0.30 108.30 111.69 B B B O4' C1' N9 DG DG DG 23 23 23 N 1 4.39 0.50 113.10 117.49 B B B N7 C8 N9 DG DG DG 23 23 23 N 1 -3.36 0.40 106.40 103.04 B B B C8 N9 C4 DG DG DG 23 23 23 N 1 6.04 0.90 103.10 109.14 B B B C4' C3' C2' DG DG DG 24 24 24 N 1 3.09 0.50 106.80 109.89 B B B O4' C1' C2' DG DG DG 24 24 24 N 1 2.71 0.30 108.30 111.01 B B B O4' C1' N9 DG DG DG 24 24 24 N 1 4.50 0.50 113.10 117.60 B B B N7 C8 N9 DG DG DG 24 24 24 N 1 -2.71 0.40 106.40 103.69 B B B C8 N9 C4 DG DG DG 24 24 24 N 1 A A C5' C4' DT DT 8 8 0.048 0.007 1.512 1.560 N 1 A A C5 C7 DT DT 10 10 0.038 0.006 1.496 1.534 N 1 A A C5' C4' DC DC 12 12 0.059 0.007 1.512 1.571 N model building X-PLOR refinement X-PLOR phasing X-PLOR NMR SOLUTION STRUCTURE OF A DNA DODECAMER DUPLEX CONTAINING A CIS-DIAMMINEPLATINUM(II) D(GPG) INTRASTRAND CROSS-LINK, THE MAJOR ADDUCT OF THE ANTICANCER DRUG CISPLATIN, 1 STRUCTURE 1 N N 2 N N 3 N N metalc 2.046 A DG 6 A N7 DG 6 1_555 A CPT 13 C PT1 CPT 1_555 metalc 2.051 A DG 7 A N7 DG 7 1_555 A CPT 13 C PT1 CPT 1_555 hydrog WATSON-CRICK A DC 1 A N3 DC 1 1_555 B DG 24 B N1 DG 12 1_555 hydrog WATSON-CRICK A DC 1 A N4 DC 1 1_555 B DG 24 B O6 DG 12 1_555 hydrog WATSON-CRICK A DC 1 A O2 DC 1 1_555 B DG 24 B N2 DG 12 1_555 hydrog WATSON-CRICK A DC 2 A N3 DC 2 1_555 B DG 23 B N1 DG 11 1_555 hydrog WATSON-CRICK A DC 2 A N4 DC 2 1_555 B DG 23 B O6 DG 11 1_555 hydrog WATSON-CRICK A DC 2 A O2 DC 2 1_555 B DG 23 B N2 DG 11 1_555 hydrog WATSON-CRICK A DT 3 A N3 DT 3 1_555 B DA 22 B N1 DA 10 1_555 hydrog WATSON-CRICK A DT 3 A O4 DT 3 1_555 B DA 22 B N6 DA 10 1_555 hydrog WATSON-CRICK A DC 4 A N3 DC 4 1_555 B DG 21 B N1 DG 9 1_555 hydrog WATSON-CRICK A DC 4 A N4 DC 4 1_555 B DG 21 B O6 DG 9 1_555 hydrog WATSON-CRICK A DC 4 A O2 DC 4 1_555 B DG 21 B N2 DG 9 1_555 hydrog WATSON-CRICK A DT 5 A N3 DT 5 1_555 B DA 20 B N1 DA 8 1_555 hydrog WATSON-CRICK A DT 5 A O4 DT 5 1_555 B DA 20 B N6 DA 8 1_555 hydrog WATSON-CRICK A DG 6 A N1 DG 6 1_555 B DC 19 B N3 DC 7 1_555 hydrog WATSON-CRICK A DG 6 A N2 DG 6 1_555 B DC 19 B O2 DC 7 1_555 hydrog WATSON-CRICK A DG 6 A O6 DG 6 1_555 B DC 19 B N4 DC 7 1_555 hydrog WATSON-CRICK A DG 7 A N1 DG 7 1_555 B DC 18 B N3 DC 6 1_555 hydrog WATSON-CRICK A DG 7 A N2 DG 7 1_555 B DC 18 B O2 DC 6 1_555 hydrog WATSON-CRICK A DG 7 A O6 DG 7 1_555 B DC 18 B N4 DC 6 1_555 hydrog WATSON-CRICK A DT 8 A N3 DT 8 1_555 B DA 17 B N1 DA 5 1_555 hydrog WATSON-CRICK A DT 8 A O4 DT 8 1_555 B DA 17 B N6 DA 5 1_555 hydrog WATSON-CRICK A DC 9 A N3 DC 9 1_555 B DG 16 B N1 DG 4 1_555 hydrog WATSON-CRICK A DC 9 A N4 DC 9 1_555 B DG 16 B O6 DG 4 1_555 hydrog WATSON-CRICK A DC 9 A O2 DC 9 1_555 B DG 16 B N2 DG 4 1_555 hydrog WATSON-CRICK A DT 10 A N3 DT 10 1_555 B DA 15 B N1 DA 3 1_555 hydrog WATSON-CRICK A DT 10 A O4 DT 10 1_555 B DA 15 B N6 DA 3 1_555 hydrog WATSON-CRICK A DC 11 A N3 DC 11 1_555 B DG 14 B N1 DG 2 1_555 hydrog WATSON-CRICK A DC 11 A N4 DC 11 1_555 B DG 14 B O6 DG 2 1_555 hydrog WATSON-CRICK A DC 11 A O2 DC 11 1_555 B DG 14 B N2 DG 2 1_555 hydrog WATSON-CRICK A DC 12 A N3 DC 12 1_555 B DG 13 B N1 DG 1 1_555 hydrog WATSON-CRICK A DC 12 A N4 DC 12 1_555 B DG 13 B O6 DG 1 1_555 hydrog WATSON-CRICK A DC 12 A O2 DC 12 1_555 B DG 13 B N2 DG 1 1_555 DNA DEOXYRIBONUCLEIC ACID, CISPLATIN, DNA, DUPLEX, DODECAMER, HMG-DOMAIN INTERACTION 1A84 PDB 1 1A84 1A84 PDB 2 1A84 1 12 1A84 1 12 1A84 A 1 1 12 13 24 1A84 13 24 1A84 B 2 1 12 BINDING SITE FOR RESIDUE CPT A 13 A CPT 13 Software 3 A DT 5 A DT 5 3 1_555 A DG 6 A DG 6 3 1_555 A DG 7 A DG 7 3 1_555 1 P 1